Show simple item record

Phase I-II study of Plitidepsin and Dacarbazine as first-line therapy for advanced melanoma.

dc.contributor.authorPlummer, R
dc.contributor.authorLorigan, Paul C
dc.contributor.authorBrown, E
dc.contributor.authorZaucha, R
dc.contributor.authorMoiseyenko, V
dc.contributor.authorDemidov, L
dc.contributor.authorSoriano, V
dc.contributor.authorChmielowska, E
dc.contributor.authorAndrés, R
dc.contributor.authorKudryavtseva, G
dc.contributor.authorKahatt, C
dc.contributor.authorSzyldergemajn, S
dc.contributor.authorExtremera, S
dc.contributor.authorde Miguel, B
dc.contributor.authorCullell-Young, M
dc.contributor.authorCalvert, H
dc.date.accessioned2013-12-20T12:12:31Z
dc.date.available2013-12-20T12:12:31Z
dc.date.issued2013-09-17
dc.identifier.citationPhase I-II study of Plitidepsin and Dacarbazine as first-line therapy for advanced melanoma. 2013, 109 (6):1451-9 Br J Canceren
dc.identifier.issn1532-1827
dc.identifier.pmid23989947
dc.identifier.doi10.1038/bjc.2013.477
dc.identifier.urihttp://hdl.handle.net/10541/308815
dc.description.abstractThis phase I-II trial compared plitidepsin 1-h infusion alone or combined with dacarbazine (DTIC) 1-h infusion as front-line therapy for advanced melanoma.
dc.language.isoenen
dc.rightsArchived with thanks to British journal of canceren
dc.titlePhase I-II study of Plitidepsin and Dacarbazine as first-line therapy for advanced melanoma.en
dc.typeArticleen
dc.contributor.departmentNorthern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, NE7 7DN, UK.en
dc.identifier.journalBritish Journal of Canceren
html.description.abstractThis phase I-II trial compared plitidepsin 1-h infusion alone or combined with dacarbazine (DTIC) 1-h infusion as front-line therapy for advanced melanoma.


This item appears in the following Collection(s)

Show simple item record